Home > Resources > Infographics > Doing our part: Partnerships to boost R&D for unmet medical needs

Doing our part: Partnerships to boost R&D for unmet medical needs

New drugs serving unmet medical needs are one of the key value drivers of research-based pharmaceutical companies. The efficiency of research and development (R&D), defined as the successful approval and launch of new medicines (output) in the rate of the monetary investments required for R&D (input), has declined since decades.

Spotlight

DeltaHealth China

DeltaHealth is an innovative healthcare provider primarily invested by Eight Roads and its affiliate Eight Roads Ventures China. As of now, it is also the first and the only medical institution with a consultation and advisory relationship with Columbia HeartSource in China. DeltaHealth is committed to establishing an integrated network of hospitals and clinics in China that specializes in cardiovascular care and always puts patients first. We aim to bring to our patients a set of innovative and personalized medical services. To achieve this, we are building on some of the great medical management practices in the West while combining the world's excellent physicians and state-of-the-art medical technology under one roof. In addition to providing diverse and high-quality healthcare services, we also strive to improve the diagnosis and treatment of cardiovascular diseases, and deliver better experience for patients. We see this as our contribution to the development of the medical syste

Other Infographics

Pharma Technology Focus

Infographic | June 3, 2022

Pharma Technology Focus is free to read on all devices.

Do patients actually watch all those pharma TV ads?

Infographic | January 13, 2020

Fewer than one in eight chronic-disease sufferers say they watch when a drug commercial comes on TV, according to one recent study of community users. And for the millennials among them, the percentage is even less so. That’s despite the $5.1 billion spent by biopharma on the medium in 2018. We take a look at these data points and many others from two recent studies on the media habits of patients and doctors.

Summary of Chloroquine and Hydroxychloroquine Drug-Drug Interactions

Infographic | April 7, 2020

COVID-19 is a rapidly emerging and devastating pandemic disease. Recently, chloroquine (CQ) and hydroxychloroquine (HCQ) have been suggested for possible off-label use for patients suffering from a more severe clinical course.

Pharmaceutical Industry World Economy Scenario

Infographic | May 20, 2022

This product titled One Page Pharmaceutical Industry World Economy Scenario Report Infographic PPT PDF Document is a completely editable document in A4 size designed in Powerpoint.

What Does The Pharma IndustryWant From CROs?

Infographic | June 16, 2022

Use Informa Pharma Intelligence’s marketing and pharma expertise to conduct industry research, produce engaging thought leadership content,

What is Adoptive Cell Therapy?

Infographic | February 5, 2020

A type of immunotherapy in which T cells are given to a patient to help the body fight diseases. In cancer therapy, T cells are usually taken from the patient’s own blood or tumor tissue, grown in large numbers in the laboratory, and then given back to the patient to help the immune system fight the cancer.

Doing our part: Partnerships to boost R&D for unmet medical needs